Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition
Different gastrointestinal disorders, including inflammatory bowel diseases (IBD), have been linked to alterations of the gut microbiota composition, namely dysbiosis. Fecal microbiota transplantation (FMT) is considered an encouraging therapeutic approach for ulcerative colitis patients, mostly as...
Main Authors: | Claudia Burrello, Maria Rita Giuffrè, Angeli Dominique Macandog, Angelica Diaz-Basabe, Fulvia Milena Cribiù, Gianluca Lopez, Francesca Borgo, Luigi Nezi, Flavio Caprioli, Maurizio Vecchi, Federica Facciotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/6/517 |
Similar Items
-
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models
by: Francesco Strati, et al.
Published: (2021-02-01) -
Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products
by: Do-Yeon Kim, et al.
Published: (2024-12-01) -
Fecal microbiota transplant – a new frontier in inflammatory bowel disease
by: Sunkara T, et al.
Published: (2018-08-01) -
Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease
by: Adrian Boicean, et al.
Published: (2023-09-01) -
Fecal Microbiota Transplantation for Chronic Pouchitis: A Systematic Review and Meta-Analysis
by: Magnus Chun, et al.
Published: (2024-11-01)